External Organizations

  1. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  2. World Bank
  3. Union for International Cancer Control (UICC)

Novartis Access Evaluation

Novartis Access
A social business program to increase access to medicines for non-communicable diseases (NCDs) through the direct sale of NCD medicines to governments and other public-sector customers in low and lower middle income countries. BU is currently conducting an evaluation of Novartis Access.

Additional Resources

Responding to Industry Initiatives to Increase Access to Medicines and Other Health Technologies in Countries
Publication by the WHO on Industry-led access to medicines

Sustainable Development Goals
Target 3.4: by 2030 reduce by one-third premature mortality from NCDs through prevention and treatment, and promote mental health and well-being.

WHO Draft NCD Framework and Targets
Draft comprehensive global monitoring framework and targets for the prevention and control of NCDs.

UNGASS Meeting on NCDs
The United Nations General Assembly Special Session (UNGASS) is a meeting of UN member states to assess and debate global issues such as health, gender, or in this case, the world’s drug control priorities.

BUSPH Center for Global Health and Development
Boston University interdisciplinary research center housed in the Department of Global Health

Pharmaceutical Program at Boston University
Graduate certificate program in pharmaceuticals at the Boston University School of Public Health